Z. D. Kanmaz Et Al. , "Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma," CANCER BIOMARKERS , vol.16, no.3, pp.489-498, 2016
Kanmaz, Z. D. Et Al. 2016. Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma. CANCER BIOMARKERS , vol.16, no.3 , 489-498.
Kanmaz, Z. D., Aras, G., Tuncay, E., Bahadir, A., Kocaturk, C., Yasar, Z. A., ... Oz, B.(2016). Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma. CANCER BIOMARKERS , vol.16, no.3, 489-498.
Kanmaz, Zehra Et Al. "Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma," CANCER BIOMARKERS , vol.16, no.3, 489-498, 2016
Kanmaz, Zehra D. Et Al. "Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma." CANCER BIOMARKERS , vol.16, no.3, pp.489-498, 2016
Kanmaz, Z. D. Et Al. (2016) . "Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma." CANCER BIOMARKERS , vol.16, no.3, pp.489-498.
@article{article, author={Zehra Dilek Kanmaz Et Al. }, title={Contribution of (18)Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma}, journal={CANCER BIOMARKERS}, year=2016, pages={489-498} }